AU2001288940A1 - Gene and sequence variation associated with cancer - Google Patents

Gene and sequence variation associated with cancer

Info

Publication number
AU2001288940A1
AU2001288940A1 AU2001288940A AU8894001A AU2001288940A1 AU 2001288940 A1 AU2001288940 A1 AU 2001288940A1 AU 2001288940 A AU2001288940 A AU 2001288940A AU 8894001 A AU8894001 A AU 8894001A AU 2001288940 A1 AU2001288940 A1 AU 2001288940A1
Authority
AU
Australia
Prior art keywords
cancer
gene
sequence variation
variation associated
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288940A
Inventor
Jackie S. Bodnar
Lawrence W. Castellani
Aurobindo Chatterjee
Pieter De Jong
Aldons J. Lusis
Jeff Ohmen
David Ross
Sherrie Tafuri
Chenyan Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2001288940A1 publication Critical patent/AU2001288940A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001288940A 2000-09-08 2001-09-07 Gene and sequence variation associated with cancer Abandoned AU2001288940A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23132200P 2000-09-08 2000-09-08
US60/231,322 2000-09-08
PCT/US2001/028182 WO2002020848A2 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with cancer

Publications (1)

Publication Number Publication Date
AU2001288940A1 true AU2001288940A1 (en) 2002-03-22

Family

ID=22868732

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001288940A Abandoned AU2001288940A1 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with cancer
AU2001290694A Abandoned AU2001290694A1 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with lipid disorder

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001290694A Abandoned AU2001290694A1 (en) 2000-09-08 2001-09-07 Gene and sequence variation associated with lipid disorder

Country Status (3)

Country Link
US (1) US20030054418A1 (en)
AU (2) AU2001288940A1 (en)
WO (2) WO2002020848A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001094420A1 (en) * 2000-06-05 2001-12-13 The Trustees Of Columbia University In The City Of New York Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
US20030199464A1 (en) * 2002-04-23 2003-10-23 Silviu Itescu Regeneration of endogenous myocardial tissue by induction of neovascularization
KR101744169B1 (en) 2013-08-12 2017-06-09 사회복지법인 삼성생명공익재단 Biomarkers for Diagnosing a Tumor Disorder and Uses Thereof
WO2021173892A1 (en) * 2020-02-28 2021-09-02 Academia Sinica Animal models of lipid metabolism and methods of treating hyperlipidemia or hyperlipidemia-related diseases

Also Published As

Publication number Publication date
US20030054418A1 (en) 2003-03-20
WO2002020847A2 (en) 2002-03-14
AU2001290694A1 (en) 2002-03-22
WO2002020848A2 (en) 2002-03-14
WO2002020847A3 (en) 2003-07-31
WO2002020848A3 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU5091201A (en) Vegf-modulated genes and methods employing them
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU1922301A (en) Differential gene expression in cancer
AU2088801A (en) Metastasis genes and uses thereof
AU2002256461A1 (en) Polypeptides and nucleic acids associated with cancer
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2002356898A1 (en) Gene amplification and overexpression in cancer
AUPQ659800A0 (en) Genetic sequences and uses therefor
AU2001242625A1 (en) Gene sequence
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
AU2001226922A1 (en) Cancer associated genes and their products
AU2001264247A1 (en) GASC1 gene
AU8026300A (en) Sodd gene expression in cancer
AU2001240103A1 (en) Reproduction-specific genes
AU2001272373A1 (en) Cgtase and dna sequence encoding same
AU2001264488A1 (en) Gene expression cassette and its use
AU2001288940A1 (en) Gene and sequence variation associated with cancer
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001291194A1 (en) Multiple region convolver with tapering
AU2001285743A1 (en) Adipose-related gene
AU1894601A (en) Novel gene and use thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof